AQST Earnings

Quarterly EPS
$-0.19
Q4 2024
$-0.24
Q1 2025
$-0.14
Q2 2025
$-0.14
Q3 2025
$-0.26
Q4 2025
$-0.07
Q1 2026
$-0.18
Q2 2026
$-0.13
Q3 2026
Latest Revenue7.6M
Latest Net Income-16496000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.137.6M-16496000-41.0%+7.1%
Q2 2026-$0.1813.8M-22864000+38.1%-28.6%
Q1 2026-$0.0714.4M-8057000+65.7%+70.8%
Q4 2025-$0.2613.0M-31860000+9.7%-36.8%
Q3 2025-$0.1412.8M-15446000-5.4%-7.7%
Q2 2025-$0.1410.0M-13548000-50.2%-366.7%
Q1 2025-$0.248.7M-22930000-27.7%-41.2%
Q4 2024-$0.1911.9M-17055000-10.1%-58.3%
Q3 2024-$0.1313.5M-11509000——
Q2 2024-$0.0320.1M-2745000——
Q1 2024-$0.1712.1M-12828000——
Q4 2023-$0.1213.2M-8111000——
Aquestive Therapeutics (AQST) — Earnings